Adverse reactions following annual ivermectin treatment of onchocerciasis in Nigeria

International Journal of Infectious Diseases

Volumn 7, Issue 2, 2003, Pages 156-159

  Oyibo, Wellington A ^a   Fagbenro Beyioku, A F ^b  

^a ADDIS ABABA UNIVERSITY   (Ethiopia)

^b UNIVERSITY OF LAGOS   (Nigeria)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIHISTAMINIC AGENT; IVERMECTIN;

ADOLESCENT; ADULT; AGED; ARTHRALGIA; ARTICLE; COMMUNITY CARE; CONTROLLED STUDY; DRUG INDUCED DISEASE; DRUG SURVEILLANCE PROGRAM; FEVER; HEADACHE; HEALTH CARE PERSONNEL; HEALTH EDUCATION; HEALTH PROGRAM; HOUSEHOLD; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; NIGERIA; ONCHOCERCIASIS; PATIENT EDUCATION; PATIENT MONITORING; PRURITUS; QUESTIONNAIRE; SCHOOL CHILD; SELF REPORT; TREATMENT OUTCOME; VERTIGO;

EID: 0038677050     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1201-9712(03)90013-0     Document Type: Article

References (18)

1. Taylor HR, Greene BM, Langham ME. Controlled clinical trial of oral and topical diethylcarbamizine in treatment of onchocerciasis. Lancet 1980; 1:943-946.
2. Taylor HR, Greene BM. The status of ivermectin in the control of onchocerciasis. Acta Leiden 1989; 59(1-2):201-206.
3. Greene BM, Dukuly ZD, Munoz B, White AT, Aziz MA. Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis. N Engl J Med 1985; 313(3): 133-138.
4. World Health Organization. Expert Committee on Onchocerciasis. Third Report. WHO Technical Report Series, No. 752. Geneva: WHO, 1987.
5. World Health Organization. Onchocerciasis and its control. Report of a WHO Expert Committee on Onchocerciasis Control. WHO Technical Report Series, No. 852. Geneva: WHO, 1995.
6. De Sole G, Remme J, Awadzi K, Accorsi S, Alley ES, Ba O. Adverse reactions after large-scale treatment of onchocerciasis with ivermectin: combined results from eight community trials. Bull WHO 1989; 67(6):707-719.
7. Rothova A, Vander Leliji A, Stilma JS, Wilson WR, Barbe RF. Side-effects of ivermectin in the treatment of onchocerciasis. Lancet 1989; 1:1439-1441.
8. Chijioke CP, Okonkwo PO. Adverse events following mass ivermectin therapy for onchocerciasis. Trans R Soc Trop Med Hyg 1993; 86:284-286.
9. Mwetta E, Hills E. Community treatment with ivermectin for onchocerciasis in the East Usambra Mountains. East Afric Med J 1994; 71(12):790-791.
10. Paque MC, Munoz B, Keyvan-Larijiani E, Dukuly Z, Greene BM, Taylor HR. Community-based treatment of onchocerciasis with ivermectin: acceptability and early adverse reactions. Bull WHO 1989; 67:721-730.
11. Burnham GM. Adverse reactions to ivermectin treatment for onchocerciasis. Results of a placebo-controlled, double-blind trial in Malawi. Trans R Soc Trop Med Hyg 1993; 87:313-317.
12. Heu-schkel C, Soboslay PT, Awissi D, Schulz-Key H. Ivermectin in the treatment of onchocerciasis: experience with community-based trial in Central Togo. Bull Soc Franc Parasitol 1990; 8(suppl 1):431.
13. Baraka OZ, Khier MM, Ahmed MK, et al. Community-based distribution of ivermectin in eastern Sudan: acceptability and early post-treatment reactions. Trans R Soc Trop Med Hyg 1995; 89:316-318.
14. Collins RC, Gonzales-Perata C, Castro J, et al. Ivermectin: reduction in prevalence and infection intensity of Onchocerca volvulus following bi-annual treatments in five Guatemalan communities. Am J Trop Med Hyg 1992; 47: 156-169.
15. Zea-Flores R, Richards FO, Gonzalez-Petratta C, et al. Adverse reactions after community treatment of onchocerciasis with ivermectin in Guatemala. Trans R Soc Trop Med Hyg 1992; 86:663-666.
16. Whitworth JA, Morgan D, Maude GH, Taylor DW. Community-based treatment with ivermectin. Lancet 1988; 2:97-98.
17. Bossinesq M, Gardon J, Gardon-Wendel N, Kamgno J, Ngoumou P, Chipaux JP. Three probable cases of Loa loa encephalopathy following ivermectin treatment for onchocerciasis. Am J Trop Med Hyg 1998; 54(4):461-469.
18. Njoo FL, Beek WMJ, Keukens HJ, et al. Ivermectin detection in serum of onchocerciasis patients: relationship to adverse reactions. Am J Trop Med Hyg 1995; 52(1): 94-97.